Announcements Trials
Browse Landscape

Status

No longer available 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 7Expanded_access 2

Sponsor

Cancer Type

Sarcoma 2Thoracic 1Other solid neoplasm 1Genitourinary 1

Conditions

Sarcoma 2Sarcoma, Synovial 1Rhabdoid Tumor 1Neoplasms 1Mesothelioma, Malignant 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Renal Cell 1

Interventions

tazemetostat 2Trabectedin 2selinexor 1olaratumab 1balstilimab 1anlotinib 1TH 302 1Proton Pump Inhibitors 1Hydrocortisone 1DOXO-EMCH 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Sarcoma × tazemetostat × Clear all
NCT04225429 2024-10-01

Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

Ipsen

No longer available
Sarcoma

Neoplasms, Sarcoma

NCT03874455 2024-03-22

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Ipsen

No longer available
GenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Carcinoma, Renal Cell, Chondrosarcoma, Sarcoma, Sarcoma, Synovial, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡